The Conversation (0)
- NORTH AMERICA EDITIONAustraliaNorth AmericaWorld
Chart
Detailed Quote
Nova Mentis Life Science Corp is a Canadian-based biotechnology company. It is engaged in developing diagnostics and psilocybin-based therapeutics for neuroinflammatory disorders. Nova uses psilocybin in the treatment of Fragile X Syndrome (FXS).
Featured Articles and Interviews
May 08, 2023
Psychedelics Stocks to Watch
Press Releases
See More Press Releases
Alert Options
No alert set
INN Article Notification
Alert Option
You will be notified when this event occurs. No additional settings needed.


